Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping
International Journal of Environmental Research and Public Health · 2025
DOI: 10.3390/ijerph22081220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Ana Rita González und 9 weiteren Autor:innen. Beteiligte Einrichtung: Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico. Hauptthemen laut MEDLINE: Precision Medicine, Health Equity, Neoplasms, Health Policy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson Innovative Medicine, Johnson & Johnson Innovative Medicine.
Abstract (Originalsprache)
This study presents and discusses evidence on the value of biomarker testing and precision medicine in Latin America through a health equity lens. It is essential to explore how to harness the benefits of precision medicine to narrow the health equity gap, ensuring all patients have access to the best cancer treatment. The methodology employed to develop this document consists of a non-systematic literature review, followed by a process of validation and feedback with a group of experts in relevant fields. Precision medicine could help reduce health inequities in Latin America by providing better diagnosis and treatment for everyone with cancer. However, its success in achieving this depends on the implementation of policies that promote equitable access. Findings indicate that the current policy landscape in the Latin American region is not conducive to improving access, reach, quality, or outcome-related problems in cancer care, nor to realizing the full potential of precision medicine. The study explores how precision medicine can advance health equity, concluding with an analysis of the challenges and recommendations for overcoming them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico.
- Cuenta de Alto Costo, Cra. 45 #103 34 Oficina 802, Bogotá 110111, Colombia.
- Health Pharma Professional Research S.A de C.V., Av. Insurgentes Sur 662-Piso 3, Col. Del Valle, Benito Juárez, Ciudad de México 03100, Mexico.
- Centro Oncologico Riojano Integral, La Rioja F5300, Argentina.
- Genome Canada, 50 Metcalfe Street, Suite 2100, Ottawa, ON K2P 1P1, Canada.
- Alexander Fleming Institute, Av. Crámer 1180-C1426ANZ, Buenos Aires C1426, Argentina.
ORCID-Profile: Diego Kaen, Allira Attwill, Carlos Barrios
Förderung
- Johnson & Johnson Innovative Medicine
- Johnson & Johnson Innovative Medicine
Zitieren
APA
González, A. R., Merchán, L. A. A., Alexander, J. A. A., Kaen, D., Lopez-Correa, C., Martin, C., Attwill, A., Marinetti, T., Rocha, J. V., & Barrios, C. (2025). Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph22081220
Vancouver
González AR, Merchán LAA, Alexander JAA, Kaen D, Lopez-Correa C, Martin C, et al. Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping. International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph22081220
BibTeX
@article{Gonzlez2025,
author = {González, Ana Rita and Merchán, Lizbeth Alexandra Acuña and Alexander, Jorge A Alatorre and Kaen, Diego and Lopez-Correa, Catalina and Martin, Claudio and Attwill, Allira and Marinetti, Teresa and Rocha, João Victor and Barrios, Carlos},
title = {Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
doi = {10.3390/ijerph22081220}
}
EUVIMED